<SEC-DOCUMENT>0001558370-24-008210-index.html : 20240515
<SEC-HEADER>0001558370-24-008210.hdr.sgml : 20240515
<ACCEPTANCE-DATETIME>20240515073958
ACCESSION NUMBER:		0001558370-24-008210
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20240515
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240515
DATE AS OF CHANGE:		20240515

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adaptimmune Therapeutics PLC
		CENTRAL INDEX KEY:			0001621227
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37368
		FILM NUMBER:		24947176

	BUSINESS ADDRESS:	
		STREET 1:		60 JUBILEE AVENUE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RX
		BUSINESS PHONE:		44 1235 430000

	MAIL ADDRESS:	
		STREET 1:		60 JUBILEE AVENUE
		STREET 2:		MILTON PARK
		CITY:			ABINGDON, OXFORDSHIRE
		STATE:			X0
		ZIP:			OX14 4RX

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adaptimmune Ltd
		DATE OF NAME CHANGE:	20141001
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>adap-20240515x8k.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: adap-20240515x8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>adap-20240515xex99d1.htm <DESCRIPTION>EX-99.1 <TEXT> Document 2 - file: adap-20240515xex99d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>adap-20240515xex99d1001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: adap-20240515xex99d1001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>adap-20240515xex99d1002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: adap-20240515xex99d1002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>5 <FILENAME>adap-20240515.xsd <DESCRIPTION>EX-101.SCH <TEXT> Document 5 - file: adap-20240515.xsd
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>6 <FILENAME>adap-20240515_lab.xml <DESCRIPTION>EX-101.LAB <TEXT> Document 6 - file: adap-20240515_lab.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>7 <FILENAME>adap-20240515_pre.xml <DESCRIPTION>EX-101.PRE <TEXT> Document 7 - file: adap-20240515_pre.xml
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>9 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 9 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EXCEL <SEQUENCE>10 <FILENAME>Financial_Report.xlsx <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 10 - file: Financial_Report.xlsx
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>11 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 11 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>12 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 12 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>14 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 14 - file: FilingSummary.html
Document 14 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>16 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 16 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>17 <FILENAME>0001558370-24-008210-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 17 - file: 0001558370-24-008210-xbrl.zip
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>19 <FILENAME>adap-20240515x8k_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 19 - file: adap-20240515x8k_htm.html
Document 19 - RAW XML: adap-20240515x8k_htm.xml
</DOCUMENT> </SEC-DOCUMENT>